HRT Basics

HRT vs. MHT: Do These Terms Mean the Same Thing?

September 24, 2026

HRT vs. MHT: Understanding the Difference is a common question for people exploring hormone treatment during menopause. This article explains in plain language what each term means, how clinicians use them, and why the words matter for your care.

Key takeaways
HRT (Hormone Replacement Therapy) and MHT (Menopause Hormone Therapy) refer to similar hormone treatments but emphasize different clinical ideas.
MHT is increasingly used to reflect treating menopausal symptoms and improving quality of life; HRT is a broader term used across ages and conditions.
Types of hormone therapy, benefits, risks, and who should avoid therapy are important to discuss with a healthcare provider.

What do the terms HRT and MHT mean?

HRT: Hormone Replacement Therapy

HRT stands for Hormone Replacement Therapy. Historically, this term has been used to describe giving hormones (most commonly estrogen, often with a progestogen) to replace hormones that the body no longer makes at the same levels—such as after menopause, surgical removal of the ovaries, or other hormonal deficiencies. HRT can also describe hormone treatment in other contexts, for example, testosterone replacement in men or estrogen therapy in younger people with ovarian insufficiency.

MHT: Menopause Hormone Therapy

MHT stands for Menopause Hormone Therapy. This term focuses specifically on treating symptoms related to the menopausal transition and the postmenopausal state. Using “MHT” emphasizes that the treatment is targeted to menopausal health—relief of hot flashes, night sweats, vaginal symptoms, sleep disruption, mood changes, and prevention of bone loss in some cases.

Why clinicians may choose one term over the other

Both terms refer to the use of hormones, often the same medicines and delivery methods. The shift toward “MHT” in many guidelines and medical discussions reflects an effort to be more precise and to avoid implying that treatment simply “replaces” hormones to a pre-menopausal baseline. MHT acknowledges that menopause is a natural life stage and that therapy is given to treat symptoms and risks that arise with that stage.

Regulatory bodies and professional societies sometimes prefer different language. Organizations such as the North American Menopause Society (NAMS) and others use terms that emphasize individualized risk–benefit discussions. Whether your clinician says HRT or MHT, the important part is the treatment plan and how it addresses your symptoms and health goals.

How these treatments are used in menopause care

Common goals of MHT/HRT during menopause

Relief of vasomotor symptoms: hot flashes and night sweats
Improvement in sleep and quality of life
Treatment of urogenital symptoms: vaginal dryness, painful intercourse, urinary symptoms (local estrogen often used)
Prevention of bone loss and reduction of fracture risk in some people
Management of more complex cases such as premature ovarian insufficiency or surgically induced menopause

Forms and routes of hormone therapy

Hormones for menopausal treatment come in many forms: oral pills, transdermal patches, gels, vaginal rings, creams, and intrauterine devices that release progestogen. The choice of formulation depends on which symptoms are present, medical history, preferences, and potential side effects.

For an overview of foundational concepts in treatment, see this page on menopause hormone therapy basics.

How HRT/MHT differs from other hormone therapies

It helps to distinguish menopausal HRT/MHT from other hormone uses:

Testosterone therapy in men: Treats low testosterone in cisgender men—different doses, goals, and monitoring.
Transgender hormone therapy: Uses estrogen, testosterone, or other agents to support gender-affirming care; protocols and targets differ from MHT.
Hormonal contraceptives: Contain estrogen and/or progestin to prevent pregnancy; doses and regimens are designed for contraception rather than menopausal symptom control.
Hormone therapy for young people with ovarian insufficiency: May use similar hormones but with different objectives (growth, bone health, fertility considerations).

In short, while the medications may overlap, the intent, dose, monitoring, and patient goals vary depending on the condition being treated.

Types of menopausal hormone therapy

Therapies can be grouped by hormones used and how they are combined:

Estrogen-only therapy: for people without a uterus (e.g., after hysterectomy).
Estrogen plus progestogen (combined therapy): for people with an intact uterus to reduce the risk of endometrial hyperplasia from unopposed estrogen.
Local vaginal estrogen: low-dose products applied locally for genitourinary symptoms with minimal systemic absorption.

Learn more about the differences between systemic options in this article on estrogen-only and combined HRT.

Benefits, risks and side effects

Potential benefits

Rapid and often substantial relief of hot flashes and night sweats.
Improved sleep, mood, and overall quality of life for many people.
Local estrogen effectively treats vaginal dryness, painful sex, and recurrent urinary symptoms.
Systemic MHT can reduce bone loss and may lower fracture risk when used appropriately.

Possible side effects

Nausea, breast tenderness, bloating, and mood changes—often dose-related and sometimes transient.
Spotting or irregular bleeding, particularly when starting or changing therapy.
Local irritation with vaginal products in some users.

Serious risks and what evidence shows

Major organizations (NAMS, ACOG, NICE and others) summarize evidence and recommend individual assessment. Key points include:

Cardiovascular disease: Starting systemic MHT in younger, recently menopausal people (generally under age 60 or within 10 years of menopause) appears to have a more favorable risk profile than initiating therapy later. However, MHT is not recommended to prevent heart disease.
Stroke: Some forms and doses of estrogen may slightly increase stroke risk, especially in older individuals or those with other risk factors.
Venous thromboembolism (VTE): Oral estrogen formulations are associated with a higher VTE risk than some transdermal options. People with a history of VTE or high clotting risk may be advised against systemic oral estrogen.
Breast cancer: Combined estrogen–progestogen therapy has been associated with a small increased risk of breast cancer with prolonged use; risk varies by type and duration of therapy. Estrogen-only therapy in people without a uterus may have a different risk profile. These are complex findings that require individualized discussion.

Who should generally avoid systemic MHT/HRT

People with any of the following should usually avoid systemic MHT or discuss alternatives with a specialist:

Current or recent breast cancer (unless a specialist advises otherwise)
Unexplained vaginal bleeding until investigated
Active or recent blood clots (venous thromboembolism)
Untreated high blood pressure or uncontrolled heart disease in some cases
Known liver disease affecting drug metabolism

These are general points. A healthcare provider will consider your complete medical history, family history, and personal priorities when recommending options.

Choosing the right approach: shared decision-making

Modern guidance emphasizes shared decision-making. That means your clinician should explain the likely benefits and potential harms of different treatments, consider your symptom burden, your individual risk factors, your preferences, and long-term goals (for example, short-term symptom control versus longer-term bone protection).

Discussions often include:

Which symptoms are most bothersome and how they affect daily life.
Medical history and risk factors for heart disease, stroke, blood clots, and breast cancer.
Family history that might influence risk.
Non-hormonal options and lifestyle measures that may help symptoms.
Follow-up and plans for reviewing therapy and stopping or switching if needed.

If you are at an earlier or later stage of reproductive aging, you may find it helpful to review information about the stages of menopause to understand timing and expectations.

Short terminology table

Term	Meaning
HRT	Hormone Replacement Therapy — broad term for hormone treatments used in various conditions, including menopause
MHT	Menopause Hormone Therapy — emphasizes treatment of menopausal symptoms and health concerns
Systemic estrogen	Estrogen taken by mouth, patch, gel, or ring that affects the whole body
Local vaginal estrogen	Low-dose estrogen applied in the vagina to treat urogenital symptoms with minimal systemic effects
Combined therapy	Estrogen plus progestogen, used for people with a uterus to protect the lining of the womb

Monitoring and follow-up

If you and your clinician decide to begin MHT/HRT, regular follow-up is important. Typical monitoring includes evaluating symptom relief and side effects, checking blood pressure and weight, and reviewing ongoing risks such as new cardiovascular risk factors or family history changes. The frequency of follow-up depends on your situation but often starts within a few months after beginning therapy and continues periodically thereafter.

Non-hormonal options and lifestyle strategies

Not everyone can or wants to use hormones. Several non-hormonal options can help manage menopausal symptoms:

Behavioral strategies for hot flashes: layering clothing, cooling measures, and avoiding triggers such as hot drinks and alcohol.
Regular exercise, which supports mood, bone health, and sleep.
Non-hormonal prescription medicines that can reduce hot flashes (these should be discussed with a clinician).
Vaginal moisturizers and lubricants for genitourinary symptoms.

Special situations

Some situations call for tailored advice:

Premature ovarian insufficiency (menopause before age 40): Hormone therapy is often recommended until around the expected age of natural menopause to protect bone and cardiovascular health.
Surgical menopause (removal of both ovaries): Symptoms can be abrupt and severe; many people benefit from systemic hormone therapy unless contraindicated.
Prior breast cancer: Decisions about hormone use require oncology and menopause specialist input; topical vaginal estrogen may still be considered after careful discussion.

Frequently Asked Questions

Are HRT and MHT exactly the same?

They refer to the same types of medicines but emphasize different perspectives. HRT is a broader term; MHT specifically frames hormone use in the context of menopausal symptom care.

Which is safer: estrogen-only or combined therapy?

Safety depends on your individual situation. Estrogen-only therapy is appropriate for people without a uterus and has a different risk profile than combined therapy. The choice depends on whether you have a uterus, your health risks, and treatment goals.

Can hormone therapy prevent heart disease?

Hormone therapy is not recommended as a strategy to prevent heart disease. Starting MHT earlier in the menopausal transition may have a different risk profile than starting later, but it should not be used solely for heart disease prevention.

How long can I stay on MHT/HRT?

There is no one-size-fits-all time limit. Many clinicians recommend regular review of symptoms and risks, and some people use therapy for short-term symptom control while others use it longer, particularly when bone protection is a concern. Decisions are individualized and should be revisited periodically.

What should I discuss with my healthcare provider?

Talk about your symptoms, medical and family history, personal priorities, and any concerns about risks. Ask about formulation options, non-hormonal alternatives, and a plan for monitoring and stopping therapy if needed.

Conclusion

HRT and MHT are closely related terms describing hormone-based approaches to managing menopausal symptoms. MHT highlights the context of menopause care, while HRT is a broader term used in other hormonal conditions as well. The choice to use hormone therapy should be made through shared decision-making with a clinician who can weigh benefits, risks, and personal preferences. If you’re considering treatment, use reliable resources, prepare questions, and have an open conversation with your healthcare provider about the best plan for your health and quality of life.

Medical disclaimer: This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Hormone therapy is not right for everyone. Always talk to your doctor or another qualified healthcare provider about your symptoms, health history and treatment options before starting, stopping or changing any medication.